On ECHEMI
Home > Drugs > Silybin meglumine

Silybin meglumine

Indication

Used for adjuvant treatment of acute and chronic hepatitis, early cirrhosis, and toxic liver damage.

Manufacturer

Hunan Qianjin Xieli Pharmaceutical Co., Ltd.

  • Founded in:

    2003-06-26
  • Address:

    No. 1361, Huanghe North Road, Tianyuan District, Zhuzhou City
  • Tax NO.:

    9143020075336479XF
  • Registered Funds:

    32 million yuan
  • Website:

  • Email:

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.